IDEXX Laboratories Inc (IDXX)
NASDAQ • Healthcare
May 20, 2026 at 16:00 UTC
About IDEXX Laboratories Inc
IDEXX Laboratories Inc is a veterinary diagnostics and software company that helps animal health providers turn samples and records into practical decisions. Clinics rely on in-clinic instruments, reference lab services, and connected practice tools that present results in clear context rather than scattered reports. The operating idea is straightforward: make testing easy to run, make data easy to read, and keep workflows familiar so teams can move from intake to treatment without losing time. In water quality and livestock testing, the same discipline applies — methods that are auditable and results that travel well between sites. Regional units adapt to local regulation while holding to shared quality systems and data safeguards. Within the healthcare ecosystem, IDEXX occupies the quiet infrastructure of veterinary care, supporting better medicine through repeatable processes that work on busy days as well as calm ones.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
IDEXX Laboratories Inc's Technical Indicators Summary
IDXX looks technically bearish as momentum and MACD are negative and price sits below several medium and long-term averages despite holding near short-term support. The ADX shows only moderate trend strength, while VWAP is above the market price and on‑balance volume is declining, implying distribution. Volatility is contained, so moves lack explosive conviction, but the weight of longer-term moving averages above the current level drives the negative tilt. Technical takeaway: Bearish — short-term support is intact but longer-term structure remains unfavorable.
| Indicator | Value |
|---|---|
RSI (14) | 45.05 |
Stochastic %K (14, 3, 3) | 27.76 |
CCI (20) | -28.23 |
WPR (14) | -61.78 |
Momentum (10) | -15.99 |
MFI | 58.77 |
MACD Level (12, 26) | -10.70 |
Bollinger Bands | $521.88 - $589.82 |
ATR (14) | $18.84 (3.44%) |
ADX (14) | 21.85 |
OBV | 5,067,023 |
VWAP | $552.83 |
Classic Pivot Point | $542.86 |
Fibonacci Pivot Point | $542.86 |
Simple Moving Averages | $546.06 - $641.53(5 indicators) |
Exponential Moving Averages | $545.03 - $605.49(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day wrapped with IDXX preserving a mild 1.30% upside gap, closing near 553.58. Into the bell, IDXX remained in a risk-off options regime, with a notably elevated put/call ratio of 1.33. IDXX edges higher as SDMA-enhanced Catalyst panels bolster diagnostics usage and recurring revenue potential amid risk-off hedging.
Price Change
from $553.61 close
-$0.05
Trading Volume
Below avg (674.7K)
582.8K
vs S&P 500 Today
Strong Outperformance
+6.04%
52-Week Position
Lower range
20.8%
Updated: May 20, 2026 at 20:07 UTC
Quote Summary
IDXX Headlines
Bamco Lifts FactSet Stake to $838 Million
March 13, 2026
Institutions Adjust Stakes in Major U.S. Corporates
March 11, 2026
Institutions Shift Positions Across Key U.S. Stocks
March 1, 2026